Abstract
This is a retrospective cross sectional study aimed to verify whether Multiplex Ligation-dependent Probe Amplification (MLPA), a quantitative molecular assay, may represent a valuable reflex test in breast cancer with equivocal HER2 expression by immunohistochemistry and HER2 gene signals/nucleus (s/n) ranging between 4.0 and 5.9 by in situ hybridization.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 143-153 |
| Numero di pagine | 11 |
| Rivista | Journal of Experimental and Clinical Cancer Research |
| Volume | 36 |
| Numero di pubblicazione | 1 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2017 |
All Science Journal Classification (ASJC) codes
- Oncologia
- Ricerca sul Cancro
Keywords
- Amplification
- HER2